Ferric carboxymaltose
- Generic Name
- Ferric carboxymaltose
- Brand Names
- Injectafer
- Drug Type
- Small Molecule
- CAS Number
- 9007-72-1
- Unique Ingredient Identifier
- 6897GXD6OE
- Background
Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013.
- Indication
Ferric carboxymaltose is an iron replacement product indicated for the treatment of iron deficiency anemia in patients ≥1 year of age who have an intolerance to, or unsatisfactory response from, oral iron therapy. It is also indicated in adult patients who have non-dialysis-dependent chronic kidney disease.
- Associated Conditions
- Iron Deficiency Anemia (IDA)
Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
- Conditions
- Iron Deficiency Anemia (IDA)Pregnancy
- Interventions
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- CMH Multan Institute of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT06911034
- Locations
- 🇵🇰
Cmh Multan Institute of Medical Sciences, Multan, Punjab, Pakistan
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants
- Conditions
- Healthy Adult
- Interventions
- Drug: Ferric Carboxymaltose Injection [Injectafer®]
- First Posted Date
- 2025-03-26
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Target Recruit Count
- 84
- Registration Number
- NCT06895993
- Locations
- 🇨🇳
Phase I clinical trial unit of the First Hospital of Jilin University, Changchun, Jilin, China
Intravenous Iron Effects on Performance at High Altitude
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- United States Army Research Institute of Environmental Medicine
- Target Recruit Count
- 24
- Registration Number
- NCT06686693
- Locations
- 🇺🇸
USARIEM, Natick, Massachusetts, United States
Hypoferritinemia Without Anemia Among Reproductive Age Females
- Conditions
- Hypoferritenemia Without Anemia (HWA)Iron Deficiency Without Anemia)
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Akram Medical Complex
- Target Recruit Count
- 1331
- Registration Number
- NCT06437080
- Locations
- 🇵🇰
Fatima Memorial Hospital, Lahore, Punjab, Pakistan
🇵🇰General Hospital Lahore, Lahore, Punjab, Pakistan
🇵🇰Sir Gangaram Hospital, Lahore, Punjab, Pakistan
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
- Conditions
- Heart Failure, SystolicIron Deficiencies
- Interventions
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Hospital de Clinicas de Porto Alegre
- Target Recruit Count
- 99
- Registration Number
- NCT06434025
- Locations
- 🇧🇷
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
IV Iron-induced Hypophosphatemia After RYGB
- Conditions
- HypophosphatemiaRoux-en-Y Gastric Bypass
- Interventions
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Lucie Favre
- Target Recruit Count
- 94
- Registration Number
- NCT06350955
- Locations
- 🇨🇭
CHUV, Lausanne, Vaud, Switzerland
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
- Conditions
- Iron DeficiencyAnaemia
- Interventions
- Drug: Ferric Carboxymaltose Injection [Ferinject]
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Target Recruit Count
- 84
- Registration Number
- NCT06080555
- Locations
- 🇨🇳
Suzhou Guochen Biotek Co., Ltd, Suzhou, Jiangsu, China
🇨🇳Boji medical technology (Beijing) co., Ltd, Beijing, Beijing, China
🇨🇳Boji Medical Technology Co., Ltd, Guangzhou, Guangdong, China
The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures
- Conditions
- AnemiaHip FracturesComplication,Postoperative
- Interventions
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Istanbul University
- Target Recruit Count
- 209
- Registration Number
- NCT06080893
- Locations
- 🇹🇷
Istanbul University, Istanbul Faculty of Medicine, Department Orthopaedics and Traumatology, Istanbul, Çapa / Fatih, Turkey
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
- Conditions
- Pregnancy AnemiaAnemia, Iron Deficiency
- Interventions
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Western Galilee Hospital-Nahariya
- Target Recruit Count
- 200
- Registration Number
- NCT06061393
The Prevalence of Iron Deficiency and the Effectiveness of Ferinject® in Patients With HFpEF (ID-HFpEF)
- Conditions
- Iron Deficiency, LatentChronic Heart Failure
- Interventions
- Other: Diet therapy
- First Posted Date
- 2023-03-31
- Last Posted Date
- 2024-11-21
- Target Recruit Count
- 100
- Registration Number
- NCT05793996
- Locations
- 🇷🇺
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.